At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 87 enrolled
Drug / intervention
Morphine Sulfate 150 mcg +1 moredrug
Likely dose
Morphine Sulfate 150 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Decreased Neuraxial Morphine and Adjunctive Peripheral Nerve Blockade to Reduce Severity of Side Effects and Opioid Use After Cesarean Delivery
In Brief
A Early Phase 1 clinical trial evaluating Morphine Sulfate 150 mcg and Morphine Sulfate 50mcg for Anesthesia. Completed, enrolled 87 participants across 1 site.
Detailed Summary
The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartSep 2020
Primary CompletionJul 2023
TodayJul 2026
First PostedFeb 20, 2020
Enrollment StartSep 9, 2020
Primary CompletionJul 5, 2023
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.4 years ago
Interventions
Morphine Sulfate 150 mcgdrug
Use of 150mcg of morphine sulfate for neuraxial block (dosing difference)
Morphine Sulfate 50mcgdrug
Use of 50mcg of morphine sulfate for neuraxial block (dosing difference)